19 June 2013
Keywords: data, aapsnb, validates, nastech, intranasal, platform, usa
Article | 03 July 2006
The USA's Nastech Pharmaceutical says that in vitro and in vivo findings with its proprietary intranasal formulation of GLP-1 indicate ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
3 July 2006
© 2013 thepharmaletter.com